Related by context. Frequent words. (Click for all words.) 62 nab paclitaxel 61 administered subcutaneously 60 plus prednisone 60 mcg kg 60 mg/m2 59 active comparator 59 mg QD 58 dose regimens 57 mcg dose 56 double blinded placebo 55 leucovorin 55 blinded placebo controlled 55 SCH # 55 peginterferon alfa 2b 55 dacarbazine 55 dose cohorts 55 Secondary endpoints 54 FOLFOX 54 peg IFN 54 placebo controlled randomized 54 relapsed refractory multiple myeloma 54 valacyclovir 54 #mg dose [003] 54 tanespimycin 54 FOLFIRI 54 thymalfasin 54 ISENTRESS 54 plus ribavirin 53 secondary efficacy endpoints 53 monotherapy 53 Pivotal Phase 53 peginterferon alfa 2a 53 dosing regimens 53 risedronate 53 #mg/kg [002] 53 mg doses 53 Laquinimod 53 Asentar 52 multicenter randomized double 52 mg calcium 52 Pivotal Phase III 52 Pharmacokinetic 52 interferon alfa 52 6R BH4 52 5 fluorouracil 52 subcutaneous injections 52 subcutaneous injection 52 intravenous doses 52 HGS ETR1 52 PRECiSE 52 dose escalation trial 52 randomized Phase III 52 administered orally 52 TELCYTA 52 TRITON TIMI 52 placebo controlled clinical 51 plus gemcitabine 51 PegIntron 51 noninferiority 51 integrase inhibitor 51 Irinotecan 51 Gabapentin GR 51 phase IIb 51 cyclophosphamide 51 fluorouracil 51 prospective randomized controlled 51 Phase 2b clinical 51 investigational oral 51 temozolomide 51 randomized #:# 51 vicriviroc 51 valopicitabine 51 mg BID 51 vinorelbine 51 multicenter clinical 51 Amrubicin 51 adalimumab 51 mg kg dose 51 nitazoxanide 51 ceftriaxone 51 plus methotrexate 51 safety tolerability pharmacokinetics 51 tolerated dose MTD 51 intramuscular injections 51 LIALDA 50 milligram doses 50 Zerenex 50 glatiramer acetate 50 tolerability 50 Phase III randomized 50 raltegravir 50 sustained virologic response 50 pharmacodynamic 50 JANUVIA 50 intravenously administered 50 Phase 1b trial 50 sitagliptin 50 temsirolimus 50 peginterferon 50 STELARA 50 GVAX